Clinical Trial Update: Intravenous Cardioversion of Atrial Fibrillation (AF) With AZD1305 [Phase 2]

View source ↗

Summary

Phase 2 trial results for intravenous AZD1305 in atrial fibrillation; the study was completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• AZD1305

Snippet

Sponsor: AstraZeneca | Conditions: Atrial Fibrillation | Phase 2 | Status: COMPLETED | Results posted: 2012-02-01